. (2023). Polypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data. Br J Gen Pract, 73, e392-e398. http://doi.org/10.3399/bjgp.2022.0295
Multimorbidity
. (2023). Socioeconomic gradient in mortality of working age and older adults with multiple long-term conditions in England and Ontario, Canada. Bmc Public Health, 23, 472. http://doi.org/10.1186/s12889-023-15370-y
. (2023). Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019. Bmc Med, 21, 21. http://doi.org/10.1186/s12916-022-02722-5
. (2022). Novel multimorbidity clusters in people with eczema and asthma: a population-based cluster analysis. Sci Rep, 12, 21866. http://doi.org/10.1038/s41598-022-26357-x
. (2022). Temporal trends and patterns in atrial fibrillation incidence: A population-based study of 3·4 million individuals. Lancet Reg Health Eur, 17, 100386. http://doi.org/10.1016/j.lanepe.2022.100386
. (2022). Health conditions in adults with HIV compared with the general population: A population-based cross-sectional analysis. Eclinicalmedicine, 47, 101392. http://doi.org/10.1016/j.eclinm.2022.101392
. (2022). Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study. Bmc Pregnancy Childbirth, 22, 120. http://doi.org/10.1186/s12884-022-04442-3
. (2022). Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England. Cardiovasc Diabetol, 21, 8. http://doi.org/10.1186/s12933-021-01435-y